Document Title
Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19?
Synopsis
ACP says evidence does not support the use of chloroquine or hydroxychloroquine alone or in combination with azithromycin as prophylaxis for COVID-19 or for treatment of patients with COVID19. The ACP Practice Points also state that physicians, in light of known harms and very uncertain evidence of benefit, may choose to treat the hospitalized COVID-19 positive patients with chloroquine or hydroxychloroquine alone or in combination with azithromycin in the context of a clinical trial using shared and informed decision-making with patients and their families.
Author
Reyna Howkins
Keywords
covid-19, covid, coronavirus, pandemic, practice point, chloroquine, hydroxychloroquine, HCQ, azithromycin, prophylaxis, treatment, SARS-CoV-2
Creation Date
Modified Date
Pages
1
Document
should_clinicians_use_chloroquine_or_hydroxychloroquine_practice_point_2020.pdf
Adobe Metadata
{"Author":"Reyna Howkins","Creator":"Microsoft\u00ae Word for Office 365","CreationDate":"2020-12-07T13:25:41-05:00","ModDate":"2020-12-07T13:37:38-05:00","Producer":"Microsoft\u00ae Word for Office 365","Title":"Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? ","Subject":"","Keywords":"covid-19, covid, coronavirus, pandemic, practice point, chloroquine, hydroxychloroquine, HCQ, azithromycin, prophylaxis, treatment, SARS-CoV-2","Pages":1}
Document Type
Guideline
Year
2020